SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003885
Filing Date
2021-11-10
Accepted
2021-11-10 06:43:16
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cere-20210930.htm   iXBRL 10-Q 3171841
2 EX-10.1 cere-ex10_1.htm EX-10.1 84795
3 EX-31.1 cere-ex31_1.htm EX-31.1 17382
4 EX-31.2 cere-ex31_2.htm EX-31.2 17369
5 EX-32.1 cere-ex32_1.htm EX-32.1 9978
6 EX-32.2 cere-ex32_2.htm EX-32.2 9984
7 GRAPHIC img31186267_0.jpg GRAPHIC 91575
  Complete submission text file 0000950170-21-003885.txt   9874526

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cere-20210930.xsd EX-101.SCH 56201
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cere-20210930_cal.xml EX-101.CAL 45631
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cere-20210930_lab.xml EX-101.LAB 429582
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cere-20210930_pre.xml EX-101.PRE 332690
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cere-20210930_def.xml EX-101.DEF 199234
13 EXTRACTED XBRL INSTANCE DOCUMENT cere-20210930_htm.xml XML 1700598
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 211394308
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences